American Options Pricing Model-Online Calculator

Follow us on LinkedIn

The binomial options pricing model is an option pricing approach used to price American-style options. An American option is a financial contract that can be exercised at any time up to and including on the expiration date. This contrasts with a European option, which can only be exercised on the expiration date.

The binomial model assumes that:

  • There is a known constant interest rate (r) over the life of the option
  • Volatility is constant over the life of the option.

The binomial model consists of a recursive method in which the value of an option at time “t” is computed from the value of the option at time “t-1”. Note that the binomial method is path-independent.

The binomial model was implemented in the calculator below.

Input

Please enter the following input parameters:

  • Spot Price: price of the underlying asset
  • Strike Price: strike of the option contract
  • Risk-Free Rate: risk-free rate
  • Volatility: volatility of the underlying asset
  • Dividend Yield: continuous dividend yield of the underlying asset
  • Time to expiration in years: time to maturity of the option contract

Output

The calculator returns the following results:

  • Price: fair value of the option contract
  • Paths of the stock price

Check out other finance calculators on our website.
Let us know what calculator you want us to develop in the comment section below.

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSThe South Park stock market jinx could be coming for high-flying weight-loss stocks
The South Park stock market jinx could be coming for high-flying weight-loss stocks

An analysis found that a stock underperformed the S&P 500 by a median of 7% in the year after being featured in the animated comedy.

Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: CollPlant reports Q1 2024 results and corporate updates
Earnings call: CollPlant reports Q1 2024 results and corporate updates
Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: Covalon turns profitable with strong Q2 performance
Earnings call: Covalon turns profitable with strong Q2 performance
Stay up-to-date with the latest news - click here
LATEST NEWSUS health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Stay up-to-date with the latest news - click here
LATEST NEWSBESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
BESREMi ® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
Stay up-to-date with the latest news - click here

Leave a Reply